However, from the Oncomine and TCGA databases, we found that KRT19 was differently expressed in various cancer types; specifically, KRT19 was significantly upregulated in both breast and colon cancers (see Figure 1a–c) [24,25]. This evidence concerns the gene KRT19 and malignant colon neoplasm.